Literature DB >> 8275420

The radiographic diagnosis and treatment of paraneoplastic central nervous system disease.

M J Glantz1, H Biran, M E Myers, J P Gockerman, M H Friedberg.   

Abstract

Paraneoplastic nervous system syndromes are being identified with increasing frequency because of greater physician awareness and the availability of serodiagnostic tests for some syndromes. Frequently, paraneoplastic syndromes develop in the setting of an indolent, limited stage, or otherwise occult malignancy. As a result, the paraneoplastic disorder often becomes the most disabling part of a patient's disease. Effective treatment appears to require early identification. For these reasons, the ability to diagnose a paraneoplastic syndrome, follow its course, and treat it successfully are important. The authors describe four patients with neurologic paraneoplastic syndromes and identical magnetic resonance imaging abnormalities. Three patients responded to immunosuppressive or immunomodulatory therapy, and in one, corresponding radiographic improvement was documented. Strategies for early diagnosis and options for treatment of paraneoplastic nervous system disorders are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275420     DOI: 10.1002/1097-0142(19940101)73:1<168::aid-cncr2820730129>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Progress in the management of paraneoplastic neurological disorders.

Authors:  Hamid Sadeghian; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  MRI of enlarged dorsal ganglia, lumbar nerve roots, and cranial nerves in polyradiculoneuropathies.

Authors:  M Castillo; S K Mukherji
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

4.  Double trouble: a tale of two radio-treatments.

Authors:  Ebere Sunny Ogbonnaya; Nikolay Peev; Sanjoy Nagaraja; Ronan Dardis
Journal:  BMJ Case Rep       Date:  2014-09-19

5.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors:  F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

6.  Immunomodulatory treatment trial for paraneoplastic neurological disorders.

Authors:  Steven Vernino; Brian Patrick O'Neill; Randolph S Marks; Judith R O'Fallon; David W Kimmel
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

7.  Chemotherapy-related posterior reversible leukoencephalopathy syndrome.

Authors:  Archit Bhatt; Muhammad U Farooq; Arshad Majid; Mounzer Kassab
Journal:  Nat Clin Pract Neurol       Date:  2009-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.